[1]
K. Shaw, “PHARMACOGENOMIC INVESTIGATION OF ADVERSE DRUG REACTIONS (ADRS): THE ADR PRIORITIZATION TOOL, APT”, J Popl Ther Clin Pharmacol, vol. 20, no. 2, Nov. 2018.